Determination of Telomerase from HeLa Cells as a Target for Screening Antitumor Agents
ZHENG Xiao\|fei , WANG Sheng\|qi, SUN Zhi\|xian
Author information+
(Institute of Radiation Medicine, Academy of Military Medical Sciences, Beijing\ 100850,China
{{custom_zuoZheDiZhi}}
{{custom_authorNodes}}
{{custom_bio.content}}
{{custom_bio.content}}
{{custom_authorNodes}}
Collapse
文章历史+
收稿日期
修回日期
出版日期
2002-02-20
2002-02-20
2002-02-20
发布日期
2002-02-20
Abstract
Telomerase, a ribonucleoprotein enzyme, has been found in immortalized but not in most somatic adult human tissues, and thus emerged as a novel target for cancer chemotherapy. Recently it has been found that telomerase is a fruitful target for oncologic drug development. A new method for screening antitumor agents by using telomerase as a target has been established according to the phenomena that the enzyme activity can be affected by some types of antitumor agents or chemicals. The telomerase was extracted from HeLa cells. The telomeric repeat amplification protocol(TRAP) was used to measure enzyme activity. Telomerase activity can be inhibited by 4 kinds of chemical compounds.
ZHENG Xiao\|fei , WANG Sheng\|qi, SUN Zhi\|xian.
Determination of Telomerase from HeLa Cells as a Target for Screening Antitumor Agents[J]. Chinese Journal of Biochemistry and Molecular Biology, 2002, 18(01): 125-128